CRON

Cronos Group Inc.

Cronos Group Inc. (CRON) has 8 SEC Form 4 filings (16 transaction rows) in the rolling window, disclosed by 0 distinct insiders. Most recent filing: May 14, 2026.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:Michael Ryan Gorenstein
  • Employees:459
  • HQ:Stayner, ON, CA
  • IPO:2018-02-27

No open-market insider trades for CRON (Cronos Group Inc.) in the last 365 days.

Why this page may be quiet. Tracefour displays Form 4 open-market purchases (P) and sales (S): the two transaction codes that signal directional conviction. Restricted stock grants, option exercises, gifts, and tax-withholding sales are filed but intentionally not shown: they're disclosure mechanics, not buy/sell decisions.

Many large-cap executives trade through pre-scheduled 10b5-1 plans set months in advance and batch-disclosed each quarter, so the latest filing on EDGAR for a mega-cap can be weeks old without any insider actually choosing to trade in that window.

See all Form 4 filings on SEC EDGAR ↗

Related companies

Cronos Group Inc. is in the Healthcare sector.